Author:
Ivanenko A. V.,Evtushenko N. A.,Gurskaya N. G.
Subject
Structural Biology,Biophysics
Reference137 articles.
1. Naso G., Petrova A. 2020. Cellular therapy options for genetic skin disorders with a focus on recessive dystrophic epidermolysis bullosa. Br. Med. Bull. 136, 30–45.
2. Kueckelhaus M., Rothoeft T., De Rosa L., Yeni B., Ohmann T., Maier C., Eitner L., Metze D., Losi L., Secone Seconetti A., De Luca M., Hirsch T. 2021. Transgenic epidermal cultures for junctional epidermolysis bullosa—5-year outcomes. N. Eng. J. Med. 385, 2264–2270.
3. Dinnes J., Deeks J.J., Chuchu N., Matin R.N., Wong K.Y., Aldridge R.B., Durack A., Gulati A., Chan S.A., Johnston L., Bayliss S.E., Leonardi-Bee J., Takwoingi Y., Davenport C., O’Sullivan C., Tehrani H., Williams H.C. 2018. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults. Cochrane Database Systematic Rev. 2018, CD011901.
4. Dourado Alcorte M., Sogayar M.C., Demasi M.A. 2019. Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa. Exper. Opin. Ther. Patents. 29, 327–337.
5. Lwin S.M., Syed F., Di W.-L., Kadiyirire T., Liu L., Guy A., Petrova A., Abdul-Wahab A., Reid F., Phillips R., Elstad M., Georgiadis C., Aristodemou S., Lovell P.A., McMillan J.R., Mee J., Miskinyte S., Titeux M., Ozoemena L., Pramanik R., Serrano S., Rowles R., Maurin C., Orrin E., Martinez-Queipo M., Rashidghamat E., Tziotzios C., Onoufriadis A., Chen M., Chan L., Farzaneh F., Del Rio M., Tolar J., Bauer J.W., Larcher F., Antoniou M.N., Hovnanian A., Thra-sher A.J., Mellerio J.E., Qasim W., McGrath J.A. 2019. Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. JCI Insight. 4, 126243.